Jump to content
  • Sign Up
0
Scott Adams

SQI Diagnostics Q3 Loss Jumps 50 Percent - GenomeWeb Daily News

Rate this topic

Recommended Posts

SQI Diagnostics Q3 Loss Jumps 50 Percent

GenomeWeb Daily News

During the quarter SQI received clearance from the US Food and Drug Administration for its SQIDworks platform and IgXPlex celiac qualitative assay. Also, Health Canada approved the second generation of the test during the quarter.

SQI Diagnostics Reports Third Quarter Financial Results Canada NewsWire (press release)

SQI Diagnostics third-quarter loss deepens to $2.7 million Winnipeg Free Press

all 8 news articles »

View the full article

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
0

×